FI68234C - Foerfarande foer framstaellning av terapeutiskt anvaendbara koplexer av 6-substituerade 9-hydroxialkylpuriner - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara koplexer av 6-substituerade 9-hydroxialkylpuriner Download PDF

Info

Publication number
FI68234C
FI68234C FI792849A FI792849A FI68234C FI 68234 C FI68234 C FI 68234C FI 792849 A FI792849 A FI 792849A FI 792849 A FI792849 A FI 792849A FI 68234 C FI68234 C FI 68234C
Authority
FI
Finland
Prior art keywords
dip
pacba
npt
cells
acid
Prior art date
Application number
FI792849A
Other languages
English (en)
Finnish (fi)
Other versions
FI792849A (fi
FI68234B (fi
Inventor
Lionel Norton Simon
John W Hadden
Original Assignee
Sloan Kettering Inst Cancer
Newport Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer, Newport Pharmaceuticals filed Critical Sloan Kettering Inst Cancer
Publication of FI792849A publication Critical patent/FI792849A/fi
Application granted granted Critical
Publication of FI68234B publication Critical patent/FI68234B/fi
Publication of FI68234C publication Critical patent/FI68234C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI792849A 1978-09-15 1979-09-13 Foerfarande foer framstaellning av terapeutiskt anvaendbara koplexer av 6-substituerade 9-hydroxialkylpuriner FI68234C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/942,802 US4221909A (en) 1978-09-15 1978-09-15 P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US94280278 1978-09-15

Publications (3)

Publication Number Publication Date
FI792849A FI792849A (fi) 1980-03-16
FI68234B FI68234B (fi) 1985-04-30
FI68234C true FI68234C (fi) 1985-08-12

Family

ID=25478620

Family Applications (1)

Application Number Title Priority Date Filing Date
FI792849A FI68234C (fi) 1978-09-15 1979-09-13 Foerfarande foer framstaellning av terapeutiskt anvaendbara koplexer av 6-substituerade 9-hydroxialkylpuriner

Country Status (27)

Country Link
US (1) US4221909A (ja)
EP (1) EP0009154B1 (ja)
JP (1) JPS5547683A (ja)
KR (1) KR840000552A (ja)
AT (1) ATE1949T1 (ja)
AU (1) AU527851B2 (ja)
CA (1) CA1122217A (ja)
CS (1) CS251060B2 (ja)
DD (1) DD146049A5 (ja)
DE (1) DE2964211D1 (ja)
DK (1) DK149857C (ja)
ES (1) ES484167A1 (ja)
FI (1) FI68234C (ja)
GR (1) GR74076B (ja)
HU (1) HU182544B (ja)
IE (1) IE48827B1 (ja)
IL (1) IL58087A (ja)
IN (1) IN153099B (ja)
MX (1) MX6521E (ja)
NO (1) NO152445C (ja)
NZ (1) NZ191483A (ja)
PH (1) PH16315A (ja)
PL (2) PL124515B1 (ja)
PT (1) PT70180A (ja)
RO (1) RO77565A (ja)
YU (1) YU41884B (ja)
ZA (1) ZA793973B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
PL318293A1 (en) 1994-07-25 1997-06-09 Alvin J Glasky Carbon monoxide dependent guanilyl cyclase modifiers
CA2199615A1 (en) * 1996-02-12 1997-08-14 Elie Abushanab Erythro-hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemia traits
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ATE499103T1 (de) 2000-07-07 2011-03-15 Spectrum Pharmaceuticals Inc Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CA2540598C (en) * 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines and analogs thereof
WO2005074946A1 (en) * 2004-02-10 2005-08-18 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3215696A (en) * 1965-11-02 Substituted adenines -and preparation thereof
US3728450A (en) * 1969-08-28 1973-04-17 Newport Pharmaceuticals Inosine derivatives
BE755361A (fr) * 1969-08-28 1971-03-01 Newport Pharmaceuticals Derives de l'inosine
US3857940A (en) * 1971-05-21 1974-12-31 Newport Pharmaceuticals Inosine derivatives
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
YU96177A (en) * 1976-04-24 1982-08-31 Wuelfing Johann A Process for obtaining adenine derivatives

Also Published As

Publication number Publication date
IE791753L (en) 1980-03-15
PL119685B1 (en) 1982-01-30
AU527851B2 (en) 1983-03-24
AU5055779A (en) 1980-03-20
IE48827B1 (en) 1985-05-29
CA1122217A (en) 1982-04-20
ES484167A1 (es) 1980-09-01
YU41884B (en) 1988-02-29
PT70180A (en) 1979-10-01
NO792792L (no) 1980-03-18
ATE1949T1 (de) 1982-12-15
PL124515B1 (en) 1983-01-31
NZ191483A (en) 1983-06-14
EP0009154B1 (en) 1982-12-08
YU224579A (en) 1983-12-31
RO77565A (ro) 1981-11-04
NO152445B (no) 1985-06-24
US4221909A (en) 1980-09-09
CS251060B2 (en) 1987-06-11
FI792849A (fi) 1980-03-16
IL58087A (en) 1983-03-31
KR840000552A (ko) 1984-02-25
EP0009154A1 (en) 1980-04-02
DK149857B (da) 1986-10-13
DD146049A5 (de) 1981-01-21
GR74076B (ja) 1984-06-06
PH16315A (en) 1983-09-05
ZA793973B (en) 1980-09-24
JPH031309B2 (ja) 1991-01-10
DK149857C (da) 1987-03-02
FI68234B (fi) 1985-04-30
DK385679A (da) 1980-03-16
NO152445C (no) 1985-10-02
HU182544B (en) 1984-02-28
DE2964211D1 (en) 1983-01-13
IN153099B (ja) 1984-06-02
JPS5547683A (en) 1980-04-04
MX6521E (es) 1985-06-27
PL218317A1 (ja) 1980-06-16

Similar Documents

Publication Publication Date Title
FI68234B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara koplexer av 6-substituerade 9-hydroxialkylpuriner
US4221794A (en) Method of imparting immunomodulating and antiviral activity
FI67847C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9-hydroxialkylpuriner
CS203093B2 (en) Method of preparing substituted purines
EP0270349B1 (en) Use of an anti-neoplastic spermine derivative in the preparation of a pharmaceutical composition
NL9000265A (nl) Ethyl-6-broom-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-fenylthiomethylindool-3-carboxylaat-hydrochloride-monohydraat, werkwijze voor de bereiding ervan en een farmaceutisch preparaat dat deze stof bevat, met antivirale, interferon inducerende en immunomodulatoire effecten.
AU663729B2 (en) 6((2-hydroxyethyl)aminoalkyl)-5,11-dioxo-5,6-dihydro-11-H- indeno-(1,2-C)isoquinoline and their use as antineoplastic agents
Hecht et al. Question of the ribosyl moiety in the promotion of callus growth by exogenously added cytokinins
US5658886A (en) Acridinone derivative, compositions containing same and a method for using same to treat Chlamydia trachomatis
Špirková et al. Synthesis and biological activity of some 2-substituted quinazolin-4-ones
Fleysher et al. Some short-chain N6-substituted adenosine analogs with antitumor properties
WO2015065243A1 (ru) 2-метилсульфанил-6-нитро-7-оксо-1, 2, 4-триазоло [5, 1-c] [1, 2, 4] триазинид l-аргининия дигидрат, обладающий активностью в отношении вируса лихорадки западного нила
US6071905A (en) Biologically active substance on the basis of tetracyclic nitrogen heterocycles of pyrimidine row
Montgomery et al. 2-Substituted derivatives of 9-. alpha.-D-arabinofuranosyladenine and 9-. alpha.-D-arabinofuranosyl-8-azaadenine
Trávníček et al. Synthesis, characterization and biological activity of two nickel (II) complexes with 6-(2-chlorobenzylamino) purine
US4720497A (en) 6-purinyl N-/2-chloroethyl/carbamate and thiocarbamate and process for the preparation thereof
US20070037838A1 (en) Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d 6,5-d']dipyrimidyne and 10-aza-analogue thereof
US20160222050A1 (en) Mutagenic nucleoside analogs and uses thereof
EP1043318A1 (en) Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
US4939156A (en) New tetramethyl-cis-diaza-bicyclo{4.2.0}octane-3,5-dione derivatives having differentiation-inducing activity and antiviral activity
O'Brien et al. Synthesis and antitumor activity of 9-substituted nitrogen mustard derivatives of naturally occurring purines

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: NEWPORT PHARMACEUTICALS INTERNATIONAL, INC.

Owner name: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH